Evidence map›Paper›PMID 12060751›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites.

Sayyed K Zaidi, Andrew J Sullivan, Andre J van Wijnen, Janet L Stein, Gary S Stein, Jane B Lian

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed.

  1. Article
  2. Role of microRNA in Diabetic Osteoporosis.Molecular biotechnology · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sayyed K ZaidiDepartment of Cell Biology and Cancer Center, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655-0106, USA.
Andrew J Sullivan
Andre J van Wijnen
Janet L Stein
Gary S Stein
Jane B Lian

Funding

Subnuclear Integration of Regulatory Signals Controlling Bone Cell FunctionP01AR048818 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STEIN, JANET L · 2002 to 2011
$14.0M
CONTROL OF OSTEOBLAST PROLIFERATION AND DIFFERENTIATIONR01AR039588 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIAN, JANE B., STEIN, GARY S. · 1990 to 2019
$8.0M
NUCLEAR MATRIX MEDIATED TRANSCRIPTIONAL CONTROL OF OSTEOBLAST GENE EXPRESSIONR01AR045688 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STEIN, GARY S. · 1998 to 2001
$922k
NIAMS NIH HHS AR 39588NIAMS NIH HHS AR 45688NIAMS NIH HHS AR 48818NIAMS NIH HHS P01 AR048818NIAMS NIH HHS R01 AR039588
6 · The paper itself

Abstract

Runx factors control lineage commitment and are transcriptional effectors of Smad signaling. Genetic defects in these pathways interfere with normal development. The in situ localization of Runx and Smad proteins must impact the mechanisms by which these proteins function together in gene regulation. We show that the integration of Runx and Smad signals is mediated by in situ interactions at specific foci within the nucleus. Activated Smads are directed to these subnuclear foci only in the presence of Runx proteins. Smad-Runx complexes are associated in situ with the nuclear matrix, and this association requires the intranuclear targeting signal of Runx factors. The convergence of Smad and Runx proteins at these sites supports transcription as reflected by BrUTP labeling and functional cooperativity between the proteins. Thus, Runx-mediated intranuclear targeting of Smads is critical for the integration of two distinct pathways essential for fetal development.

Indexed as

Neoplasm ProteinsTranscription, GeneticAmino Acid SubstitutionAnimalsBone Morphogenetic Protein 2Bone Morphogenetic ProteinsBone NeoplasmsCell NucleusCore Binding Factor alpha SubunitsDNA-Binding ProteinsHeLa CellsHumansMutagenesis, Site-DirectedOsteosarcomaPhosphoproteinsRatsBMP2 protein, humanBmp2 protein, ratBone Morphogenetic Protein 2Bone Morphogenetic ProteinsCore Binding Factor alpha SubunitsDNA-Binding ProteinsNeoplasm ProteinsPhosphoproteinsrecombinant human bone morphogenetic protein-2Recombinant ProteinsSmad5 ProteinSMAD5 protein, humanSmad5 protein, ratTrans-ActivatorsTranscription FactorsTransforming Growth Factor beta

Identifiers

PMID12060751
PMCPMC123018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.